ASPI NASDAQ
ASP Isotopes Inc. Common Stock
1W: +1.5%
1M: -20.8%
3M: -41.8%
YTD: -63.4%
1Y: -79.0%
3Y: +96.2%
$2.06
+0.04 (+1.98%)
Weekly Expected Move ±11.9%
$1
$2
$2
$2
$2
Credit Risk of going bust: higher than 92% of companies Debt: 46.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.30 (down 86%), ASP Isotopes Inc. Common Stock would be worth roughly what it owes.
Total debt $269.6M against a stock market value of $315.8M.
Distance to default 1.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $159.9M (short-term plus half of long-term), stock volatility 98.4%; Altman Z -0.34. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.30 (down 86%), ASP Isotopes Inc. Common Stock would be worth roughly what it owes.
Total debt $269.6M against a stock market value of $315.8M.
Distance to default 1.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $159.9M (short-term plus half of long-term), stock volatility 98.4%; Altman Z -0.34. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-11-03
Earliest Filing
2026-01-30
Latest Filing
partner: 6
target: 4
investor: 2
Counterparties (Filed by ASPI)
12 relationshipsCompanies named in ASPI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Opeongo, Inc. | — | investor | ASP Isotopes Inc. purchased Series Seed-1 Preferred Stock from Opeongo, Inc. | 2026-01-30 | View |
| Renergen Limited | — | target | Acquired by ASP Isotopes Inc. in a stock-for-stock transaction via a scheme of arrangement. | 2026-01-07 | View |
| Renergen Limited | — | target | Target of acquisition via scheme of arrangement; borrower in term loan facility. | 2025-11-28 | View |
| IsoBio, Inc. | — | investor | ASP Isotopes Inc. purchased 2,000,000 shares of IsoBio's Series Seed-1 Preferred Stock for $2.50 per share. | 2025-07-30 | View |
| Blank Rome LLP | — | partner | Provided legal opinion on the underwriting agreement | 2025-07-24 | View |
| QLE TP Funding SPE LLC | — | partner | Borrower entity wholly owned by ASP Isotopes Inc. entering the loan agreement | 2025-05-22 | View |
| K2025267858 (South Africa) (Pty) Ltd | — | partner | Project company formed to operate the uranium enrichment facility in South Africa | 2025-05-22 | View |
| Quantum Leap Energy LLC | — | partner | Guarantor of the loan agreement and owner of Borrower equity | 2025-05-22 | View |
| ASP Isotopes UK Limited | ASPI | partner | Licensor of uranium and lithium separation technologies to QLE in exchange for royalties. | 2024-02-29 | View |
| Quantum Leap Energy Limited | — | partner | QLE's UK subsidiary and licensee of ASP Isotopes UK Limited's technologies. | 2024-02-29 | View |
| Nucleonics Imaging Proprietary Limited | — | target | Seller of 51% of Pet Labs Pharmaceuticals Proprietary Limited shares to ASP Isotopes Inc. | 2023-11-03 | View |
| Pet Labs Pharmaceuticals Proprietary Limited | — | target | Target company whose shares are being acquired by ASP Isotopes Inc. | 2023-11-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-26 | Regulation FD; Exhibits | View | |
| 2026-10-15 | Regulation FD; Exhibits | View | |
| 2026-10-02 | Regulation FD | View | |
| 2026-09-08 | Regulation FD; Exhibits | View | |
| 2026-08-20 | Regulation FD; Exhibits | View | |
| 2026-08-20 | Material Agreement; Termination of Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-08-18 | Regulation FD; Exhibits | View | |
| 2026-08-06 | Regulation FD; Exhibits | View | |
| 2026-08-05 | Regulation FD; Exhibits | View | |
| 2026-08-04 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-30 | Regulation FD; Exhibits | View | |
| 2026-07-28 | Regulation FD; Exhibits | View | |
| 2026-07-21 | Regulation FD; Exhibits | View | |
| 2026-07-16 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-07-16 | Other Events; Exhibits | View | |
| 2026-06-25 | Regulation FD; Exhibits | View | |
| 2026-06-25 | Material Agreement; Unregistered Equity Sales; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-06-23 | Regulation FD; Exhibits | View | |
| 2026-05-26 | Regulation FD; Exhibits | View | |
| 2026-05-20 | Regulation FD | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR